Previous Close | 7.44 |
Open | 7.53 |
Bid | 6.47 x 800 |
Ask | 8.89 x 1000 |
Day's Range | 7.41 - 7.85 |
52 Week Range | 5.10 - 43.00 |
Volume | |
Avg. Volume | 87,532 |
Market Cap | 795.995M |
Beta (5Y Monthly) | 1.44 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) will effect a 1-for-50 reverse stock split of its common stock. The reverse stock split is expected to become effective and commence trading on a post-split basis at the market's opening on April 19. Diffusion's reverse stock split was approved by the Company's stockholders at a special meeting earlier today. The Company expects that the split is part of its strategy to regain compliance with the $1.00 minimum bid price requirement of the Nasdaq Capit
In this article, we discuss 10 biotech penny stocks with growth catalysts. If you want to see some more stocks in this selection, check out 5 Biotech Penny Stocks with Growth Catalysts. According to Global Market Insights, the market for biotech in 2020 was valued at $497 billion, and it is forecasted to grow to […]
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...